These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22773948)

  • 1. Reduced Na(+) and higher K(+) channel expression and function contribute to right ventricular origin of arrhythmias in Scn5a+/- mice.
    Martin CA; Siedlecka U; Kemmerich K; Lawrence J; Cartledge J; Guzadhur L; Brice N; Grace AA; Schwiening C; Terracciano CM; Huang CL
    Open Biol; 2012 Jun; 2(6):120072. PubMed ID: 22773948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action potential wavelength restitution predicts alternans and arrhythmia in murine Scn5a(+/-) hearts.
    Matthews GD; Guzadhur L; Sabir IN; Grace AA; Huang CL
    J Physiol; 2013 Sep; 591(17):4167-88. PubMed ID: 23836691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory dispersion promotes conduction disturbance and arrhythmias in a Scn5a (+/-) mouse model.
    Martin CA; Grace AA; Huang CL
    Pflugers Arch; 2011 Oct; 462(4):495-504. PubMed ID: 21779762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal interventricular differences in tissue architecture underlie right ventricular susceptibility to conduction abnormalities in a mouse model of Brugada syndrome.
    Kelly A; Salerno S; Connolly A; Bishop M; Charpentier F; Stølen T; Smith GL
    Cardiovasc Res; 2018 Apr; 114(5):724-736. PubMed ID: 29267949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrhythmic substrate, slowed propagation and increased dispersion in conduction direction in the right ventricular outflow tract of murine Scn5a+/- hearts.
    Zhang Y; Guzadhur L; Jeevaratnam K; Salvage SC; Matthews GD; Lammers WJ; Lei M; Huang CL; Fraser JA
    Acta Physiol (Oxf); 2014 Aug; 211(4):559-73. PubMed ID: 24913289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RyR2-P2328S mutation downregulates Nav1.5 producing arrhythmic substrate in murine ventricles.
    Ning F; Luo L; Ahmad S; Valli H; Jeevaratnam K; Wang T; Guzadhur L; Yang D; Fraser JA; Huang CL; Ma A; Salvage SC
    Pflugers Arch; 2016 Apr; 468(4):655-65. PubMed ID: 26545784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of L-type Ca2+ channel antagonism on ventricular arrhythmogenesis in murine hearts containing a modification in the Scn5a gene modelling human long QT syndrome 3.
    Thomas G; Gurung IS; Killeen MJ; Hakim P; Goddard CA; Mahaut-Smith MP; Colledge WH; Grace AA; Huang CL
    J Physiol; 2007 Jan; 578(Pt 1):85-97. PubMed ID: 17110414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable Na(v)1.5 protein expression from the wild-type allele correlates with the penetrance of cardiac conduction disease in the Scn5a(+/-) mouse model.
    Leoni AL; Gavillet B; Rougier JS; Marionneau C; Probst V; Le Scouarnec S; Schott JJ; Demolombe S; Bruneval P; Huang CL; Colledge WH; Grace AA; Le Marec H; Wilde AA; Mohler PJ; Escande D; Abriel H; Charpentier F
    PLoS One; 2010 Feb; 5(2):e9298. PubMed ID: 20174578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of reentrant spontaneous polymorphic ventricular tachycardia in a Scn5a+/- mouse model.
    Martin CA; Guzadhur L; Grace AA; Lei M; Huang CL
    Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1853-62. PubMed ID: 21378142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
    Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
    PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor β receptor inhibition prevents ventricular fibrosis in a mouse model of progressive cardiac conduction disease.
    Derangeon M; Montnach J; Cerpa CO; Jagu B; Patin J; Toumaniantz G; Girardeau A; Huang CLH; Colledge WH; Grace AA; Baró I; Charpentier F
    Cardiovasc Res; 2017 Apr; 113(5):464-474. PubMed ID: 28339646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents.
    Hu D; Barajas-Martínez H; Medeiros-Domingo A; Crotti L; Veltmann C; Schimpf R; Urrutia J; Alday A; Casis O; Pfeiffer R; Burashnikov E; Caceres G; Tester DJ; Wolpert C; Borggrefe M; Schwartz P; Ackerman MJ; Antzelevitch C
    Heart Rhythm; 2012 May; 9(5):760-9. PubMed ID: 22155597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant voltage-gated Na
    Clatot J; Zheng Y; Girardeau A; Liu H; Laurita KR; Marionneau C; Deschênes I
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1250-H1257. PubMed ID: 30118344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCN5A mutations in Brugada syndrome are associated with increased cardiac dimensions and reduced contractility.
    van Hoorn F; Campian ME; Spijkerboer A; Blom MT; Planken RN; van Rossum AC; de Bakker JM; Wilde AA; Groenink M; Tan HL
    PLoS One; 2012; 7(8):e42037. PubMed ID: 22876298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonlinearity between action potential alternans and restitution, which both predict ventricular arrhythmic properties in Scn5a+/- and wild-type murine hearts.
    Matthews GD; Guzadhur L; Grace A; Huang CL
    J Appl Physiol (1985); 2012 Jun; 112(11):1847-63. PubMed ID: 22461438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brugada syndrome: clinical presentation and genotype-correlation with magnetic resonance imaging parameters.
    Rudic B; Schimpf R; Veltmann C; Doesch C; Tülümen E; Schoenberg SO; Borggrefe M; Papavassiliu T
    Europace; 2016 Sep; 18(9):1411-9. PubMed ID: 26511399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional profiles of genes related to electrophysiological function in Scn5a
    Takla M; Edling CE; Zhang K; Saadeh K; Tse G; Salvage SC; Huang CL; Jeevaratnam K
    Physiol Rep; 2021 Oct; 9(19):e15043. PubMed ID: 34617689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of SCN5A in mouse heart mimics human syndrome of enhanced atrioventricular nodal conduction.
    Liu GX; Remme CA; Boukens BJ; Belardinelli L; Rajamani S
    Heart Rhythm; 2015 May; 12(5):1036-45. PubMed ID: 25623181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De Novo Mutation in the SCN5A Gene Associated with Brugada Syndrome.
    Wang L; Meng X; Yuchi Z; Zhao Z; Xu D; Fedida D; Wang Z; Huang C
    Cell Physiol Biochem; 2015; 36(6):2250-62. PubMed ID: 26279430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arrhythmogenic consequences of Na+ channel mutations in the transmurally heterogeneous mammalian left ventricle: analysis of the I1768V SCN5A mutation.
    Flaim SN; Giles WR; McCulloch AD
    Heart Rhythm; 2007 Jun; 4(6):768-78. PubMed ID: 17556201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.